AU Patent

AU2021251208A1 — Compositions and methods for treating and preventing lung disease

Assigned to University of Arizona · Expires 2022-11-10 · 4y expired

What this patent protects

Provided herein are compositions and methods for treating and preventing lung disease. In particular, provided herein are surfactant protein-A (SP-A) peptide analogies (e.g., SP-A peptidomimetics) and uses thereof in the treatment and prevention of lung disease (e.g., asthma or C…

USPTO Abstract

Provided herein are compositions and methods for treating and preventing lung disease. In particular, provided herein are surfactant protein-A (SP-A) peptide analogies (e.g., SP-A peptidomimetics) and uses thereof in the treatment and prevention of lung disease (e.g., asthma or COPD).

Drugs covered by this patent

Patent Metadata

Patent number
AU2021251208A1
Jurisdiction
AU
Classification
—
Expires
2022-11-10
Drug substance claim
No
Drug product claim
No
Assignee
University of Arizona
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.